Get the Stockscreener App
0.14
28.24%
-0.0551
After Hours:
.14
Aditxt Inc stock is traded at $0.14, with a volume of 3.89M.
It is down -28.24% in the last 24 hours and down -82.38% over the past month.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues. The company operates in one segment, which is focused on the discovery and development of biopharmaceutical products.
See More
Previous Close:
$0.1951
Open:
$0.15795
24h Volume:
3.89M
Relative Volume:
3.17
Market Cap:
$126.63K
Revenue:
$3,200
Net Income/Loss:
$-42.79M
P/E Ratio:
-0.000019
EPS:
-7534.7458
Net Cash Flow:
$-25.70M
1W Performance:
-43.78%
1M Performance:
-82.38%
6M Performance:
-99.66%
1Y Performance:
-99.99%
1-Day Range:
$0.117
$0.1611
1-Week Range:
$0.117
$0.2294
52-Week Range:
$0.117
$2,495.04
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909-488-0844
Address
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
0.14 | 176.46K | 3,200 | -42.79M | -25.70M | -7,534.75 |
VRTX
Vertex Pharmaceuticals Inc
|
429.85 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
709.21 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
811.09 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.93 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.14 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aditxt Inc Stock (ADTX) Latest News
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
ADTX - Finviz
Aditxt to implement 1-for-8 reverse stock split on March 9 - Investing.com Nigeria
Aditxt Shareholders Approve Reverse Split and Governance Measures - The Globe and Mail
Aditxt, Inc. Files Form 8-K Current Report with SEC – Company Details, Address, and Nasdaq Listing Information - Minichart
Aditxt (ADTX) investors approve reverse split authority and elect full board - Stock Titan
ADTX Stock Price, Quote & Chart | ADITXT INC (NASDAQ:ADTX) - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
HRT Financial LP sells $9,338 in Aditxt stock By Investing.com - Investing.com Australia
HRT Financial LP sells $9,338 in Aditxt stock - Investing.com
HRT Financial LP trims Aditxt (NASDAQ: ADTX) stake with open-market sales - Stock Titan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
HRT Financial buys $24,060 Aditxt shares, sells $3,594 By Investing.com - Investing.com India
148.3M Warrant Shares Registered for Resale by Aditxt (NASDAQ: ADTX) - Stock Titan
HRT Financial buys $24,060 Aditxt shares, sells $3,594 - Investing.com
Ten percent owner HRT Financial LP trades Aditxt (ADTX) Class A shares - Stock Titan
HRT Financial LP reports insider stake in Aditxt, Inc. (ADTX) on Form 3 - Stock Titan
Aditxt announces 1-for-8 reverse stock split - MSN
ADTX (Aditxt Inc.) shares drop 3.13% following its steeply unprofitable Q3 2025 quarterly earnings release.Buy Rating - Xã Thanh Hà
ADTX (Aditxt Inc.) reports Q3 2025 earnings, shares post small gains amid limited available financial metrics.Sector Outperform - UBND thành phố Hải Phòng
[EFFECT] Aditxt, Inc. SEC Filing - Stock Titan
Aditxt (ADTX) Precision Oncology Subsidiary Featured in Key Canc - GuruFocus
Aditxt (ADTX) Stock Stock Repair (Trend Weakens) 2026-04-20Community Breakout Alerts - Xã Thanh Hà
Standard HER2 test fell short as Dana-Farber assessed Enhertu outcomes - Stock Titan
Aditxt announces $1.25 million private placement of senior unsecured notes By Investing.com - Investing.com South Africa
Aditxt Announces New Note Financing and Debt Obligations - TipRanks
Aditxt announces $1.25 million private placement of senior unsecured notes - Investing.com
Debt financing: Aditxt (NASDAQ: ADTX) sells $1.25M senior notes - Stock Titan
Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law - ADVFN
Aditxt (NASDAQ: ADTX) registers 148.3M shares issuable on warrants - Stock Titan
Aditxt, Inc. announced that it has received $1 million in funding - marketscreener.com
Is Aditxt (ADTX) Stock trading above fair value | Price at $0.52, Up 0.19%Top Trending Breakouts - Cổng thông tin điện tử Tỉnh Sơn La
Ignite Proteomics LLC Reports 2025 Financial Results and Acquisition by Aditxt, Inc - Minichart
12 Health Care Stocks Moving In Tuesday's Intraday Session - Sahm
Bull Bear: Can Aditxt Inc grow without dilution2026 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn
Ignite deal: Aditxt (NASDAQ: ADTX) records $36,551K goodwill - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - Benzinga
Will Aditxt (ADTX) Stock Outperform S&P 500 | Price at $0.61, Down 22.71%Low Risk Entry - Xã Thanh Hà
Setup Watch: Can Aditxt Inc grow without external funding2026 Setups & Long-Term Safe Investment Plans - baoquankhu1.vn
ADTX | Aditxt, Inc. Common Stock Executive Compensation - Quiver Quantitative
Aditxt (NASDAQ: ADTX) seeks reverse stock split and say-on-pay nod - Stock Titan
Aditxt regains compliance with Nasdaq listing standards following equity increase - Investing.com
Aditxt regains Nasdaq compliance after equity rises to $3.95M - TradingView — Track All Markets
Aditxt (NASDAQ: ADTX) back in line with Nasdaq equity listing rules - Stock Titan
Aditxt Inc Stock (ADTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):